Paper presentation on Uterine Fibroids Impact only on Women’s Health and Quality of Life for gynec resident in pdf form with white background and black font
Reading File
Reading File
Finding Sources
Searching PubMed
"uterine fibroids" AND "quality of life"
Finding Sources
Reading Article
Reading Article
Finding Sources
Searching PubMed
"uterine fibroids" AND "women health" AND prevalence
Finding Sources
Searching PubMed
"leiomyoma" AND "reproductive outcomes" AND fertility
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Running Command
Writing File
Editing File
Running Command
Running Command
Running Command
Paper presentation on Uterine Fibroids Impact only on Women’s Health and Quality of Life for gynec resident in pdf form with white background and black font
Finding Sources
Searching PubMed
"uterine fibroids" AND "quality of life"
Finding Sources
Reading Article
Running Command
Running Command
Running Command
Your PDF paper presentation is ready:
Uterine Fibroids Womens Health QoL
PDF Document · PDF
Here is what the document covers across 11 sections (~13 pages, A4, white background, black font):
| Section | Content |
|---|---|
| Cover page | Dark professional cover with title, subtitle, section overview |
| Table of Contents | All 11 sections with subtitles |
| 1. Introduction | Definition, significance, key facts box |
| 2. Epidemiology & Risk Factors | Prevalence, incidence data, racial disparities, risk factor table |
| 3. Pathophysiology & Classification | MED12 mutations, histopathology, FIGO 0-8 classification table |
| 4. Clinical Manifestations | AUB-L mechanisms, pelvic pain, urinary symptoms, symptom frequency table |
| 5. Reproductive Health Impact | Infertility by location, miscarriage, obstetric complication table (OR=2.2/2.6), recurrence rates |
| 6. Mental Health Impact | Depression, anxiety, body image, social isolation - validated tool table (PHQ-9, GAD-7, DASS-21) |
| 7. QoL Assessment | UFS-QoL, SF-36, EQ-5D, PBAC instruments; 7-domain QoL impairment table; evidence highlight box (Neumann et al. 2024, 67 studies) |
| 8. Socioeconomic Burden | USD 34.4 billion burden, productivity loss, health equity |
| 9. Management Overview | Medical drug table, surgical procedures, UAE/HIFU/RFA with PMID citations |
| 10. Conclusions | 9 key clinical takeaways table |
| 11. References | 15 peer-reviewed sources (textbooks + PubMed systematic reviews 2021-2026) |
Sources used: Berek & Novak's Gynecology, Creasy & Resnik's Maternal-Fetal Medicine, Robbins & Kumar Pathology, and 8 PubMed systematic reviews/meta-analyses (2021-2026) including the landmark Neumann et al. 2024 (PMID 38246400).
This is a shared conversation. Sign in to Orris to start your own chat.